One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Hanger logo
Hanger HNGR
report update icon

Quarterly report 2022-Q2
added 05-23-2026

Hanger Financial Ratios 2021-2008 | HNGR

Brief overview of Hanger's market valuation

The review covers five available annual periods spanning 2012 to 2021.

Market valuation is represented by P/E 16.67x (median 20.5x), EV/EBITDA 14.51x (median 14.58x), P/S 0.62x (median 0.74x). The combined ratio level is close to the company's five-year norm at a -3.8% deviation. No clear premium or discount is visible.

At the current P/E, inverse earnings yield is 6%, a useful bridge between price and business earnings.

The latest available business-quality ratios are ROE 38.1%, ROA 4.2%, ROCE 66%. Current resource returns are convincing and help explain a higher market valuation.

PEG is 0.43x. Price is low relative to embedded growth, though the ratio depends heavily on forecast quality.

Cash turnover speed was broadly preserved, with the cycle moving from 70.5 days to 61.9 days.

Overall assessment

Hanger's valuation and business quality look relatively balanced, with no pronounced distortion in either direction.

Annual Financial Ratios Hanger

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008
16.7 20.4 33.1 -899.0 -5.5 -4.1 -1.5 -40.2 98.2 20.5 11.9 - - -

P/S

0.6 0.8 0.8 0.7 0.6 0.4 0.5 0.8 1.1 1.0 0.7 - - -

EPS

1.1 1.0 0.7 -0.0 -2.9 -3.0 -8.8 -0.1 0.3 1.4 1.6 0.7 1.1 -

EV (Enterprise Value)

1.53 B 1.53 B 1.67 B 1.4 B 1.24 B 1.11 B 1.23 B 1.58 B 1.9 B 1.7 B 1.31 B 661 M -84.6 M -58.4 M

EBITDA per Share

2.73 2.81 2.72 2.61 0.56 -0.74 -8.51 1.88 2.06 4.19 4.38 3.08 3.4 -

EV/EBITDA

14.5 14.4 16.5 14.6 61.2 -42.2 -4.1 23.9 26.3 11.8 8.9 6.7 -0.8 -

PEG

0.43 0.95 -0.37 9.72 0.03 0.03 0.01 6.46 -10.01 1.08 0.08 - - -

P/B

6.4 15.3 95.8 -35.2 -20.5 6.6 2.9 1.8 2.4 2.1 1.5 - - -

P/CF

19.3 5.0 15.5 9.8 19.1 6.3 8.1 15.4 15.3 13.9 19.2 - - -

ROE %

38.11 74.92 289.61 3.91 373.15 -162.76 -197.94 -3.92 2.45 10.99 14.55 5.89 11.43 -

ROA %

4.21 4.02 3.27 -0.12 -16.34 -14.10 -33.61 -1.53 0.99 4.00 4.88 2.02 4.12 -

ROCE %

65.96 10.20 10.32 11.22 -4.05 -12.78 -46.29 2.50 3.24 10.25 11.77 22.11 28.66 -

Current Ratio

1.1 1.1 1.0 1.0 1.0 1.1 1.2 1.5 1.7 1.6 1.6 1.5 - -

DSO

45.7 52.5 50.4 50.5 51.0 55.9 59.7 59.3 55.9 56.4 51.2 - - -

DIO

75.2 75.2 66.6 68.6 69.4 68.6 69.1 78.9 456.7 146.2 119.0 62.9 - -

DPO

59.1 59.0 51.1 52.2 49.9 53.5 52.0 48.0 160.1 33.9 31.7 18.9 - -

Operating Cycle

120.9 127.7 117.0 119.1 120.4 124.5 128.8 138.2 512.6 202.6 170.2 62.9 - -

Cash Conversion Cycle

61.9 68.6 65.9 66.9 70.5 71.0 76.7 90.1 352.5 168.8 138.5 44.0 - -

All numbers in USD currency

Quarterly Financial Ratios Hanger

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

- - 0.26 -0.21 - 0.55 0.26 -0.09 0.42 0.18 0.82 -0.42 0.5 0.15 0.27 -0.19 0.12 0.12 0.35 -0.62 -2.32 -0.11 0.05 -0.49 -2.25 -0.21 -0.01 -0.49 -8.85 0.09 0.04 -0.45 -0.1 -0.25 0.36 0.17 0.34 0.62 0.4 0.27 - 0.5 0.51 0.25 - 0.46 0.46 0.2

EBITDA per Share

- - 0.74 0.14 - 0.87 0.73 0.26 0.98 0.57 1.26 -0.01 0.96 0.72 0.85 0.18 0.86 0.67 0.8 0.27 -0.71 0.53 0.72 0.02 -1.63 K 462 563 -151 -9.91 K 613 714 90 0.6 0.25 1.09 0.75 1.23 1.41 1.32 0.92 - 1.28 1.29 0.88 - 1.16 1.21 0.8

ROE %

24.32 24.32 40.22 25.38 32.73 64.25 61.76 194.82 300.00 465.76 404.60 209.68 133.97 -83.67 -60.68 -51.33 -31.83 289.46 321.35 352.14 373.15 -51.80 -71.81 -66.20 -141.26 -208.34 -202.52 -201.96 -193.53 -3.14 -5.60 -3.85 0.57 3.73 9.43 9.99 10.82 11.98 11.87 11.19 9.35 13.12 13.45 11.12 9.16 3.77 3.94 1.45

ROA %

2.46 2.46 3.55 2.13 2.96 4.65 3.12 5.37 3.93 4.47 4.46 2.41 3.30 1.71 1.64 2.30 -0.28 -14.10 -15.40 -17.09 -16.34 -13.91 -14.15 -14.44 -13.59 -35.30 -34.16 -34.00 -33.35 -1.18 -2.10 -1.30 0.40 1.67 4.09 4.30 4.63 5.10 4.87 4.50 3.73 5.15 5.14 4.19 3.42 1.42 1.45 0.55

ROCE %

42.93 42.93 74.38 61.88 64.23 121.40 133.20 288.16 341.38 567.26 404.28 112.04 61.18 -325.73 -265.42 -217.18 -224.81 5.30 33.48 32.38 67.56 -163.97 -126.29 -61.87 -107.43 -225.89 -227.13 -229.57 -219.52 6.55 3.94 5.01 9.23 13.93 21.27 23.78 25.47 25.80 26.40 24.47 20.06 27.70 28.74 25.48 20.54 7.64 8.40 4.50

Current Ratio

- - 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 0.9 0.9 1.0 1.0 1.0 1.0 1.1 1.2 1.2 1.2 1.2 1.6 1.6 1.6 1.5 1.6 1.8 1.8 1.7 1.8 1.8 1.7 1.6 1.7 1.7 1.6 1.6 1.6 1.6 1.6

DSO

- - 42.5 50.9 - 41.1 39.5 47.4 41.1 42.1 47.8 56.3 46.2 47.9 46.3 54.2 44.3 46.2 44.6 53.3 46.7 51.8 50.7 56.8 46.1 50.0 51.0 62.6 54.4 54.7 54.0 65.2 55.6 64.7 69.4 71.5 59.3 62.6 55.8 64.2 - 13.4 50.0 56.9 - 48.3 50.6 -

DIO

- - 70.9 76.6 - 77.8 76.0 78.7 69.8 70.8 81.8 69.3 66.0 70.8 70.4 72.5 65.6 69.8 69.5 73.8 66.2 70.0 71.8 71.2 67.2 74.6 72.4 70.5 68.3 70.8 74.2 75.8 76.4 125.5 138.9 111.8 123.5 135.7 132.2 131.8 - 136.5 134.1 130.9 - 118.5 122.1 -

DPO

- - 52.0 54.5 - 55.4 51.2 58.9 59.6 58.5 61.0 48.9 47.0 51.2 51.1 55.8 50.6 51.5 51.5 52.5 46.2 48.9 50.1 51.3 51.6 65.5 56.6 49.6 52.1 50.5 54.3 54.6 47.9 41.7 32.7 40.8 41.9 32.1 29.7 28.0 - 30.9 30.2 29.6 - 25.4 27.1 -

Operating Cycle

- - 113.4 127.5 - 118.9 115.5 126.1 113.1 123.5 144.7 130.2 110.9 117.8 119.8 130.0 109.4 118.0 118.2 129.1 113.0 121.8 122.5 128.1 113.3 124.5 123.3 133.0 122.8 125.4 128.2 141.0 132.1 147.2 145.2 156.8 144.7 185.5 219.2 228.9 - 153.6 199.3 198.4 - 180.6 182.5 -

Cash Conversion Cycle

- - 61.4 73.0 - 63.5 64.4 67.2 52.8 57.2 64.3 72.1 66.4 71.0 71.4 75.2 57.2 61.9 61.3 74.0 66.7 72.9 72.4 76.8 61.7 59.0 66.7 83.4 70.7 75.0 73.8 86.5 84.1 98.4 99.1 107.7 96.0 140.1 178.7 190.1 - 122.2 167.6 167.2 - 151.1 152.5 -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Hanger, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Care facilities industry

Issuer Price % 24h Market Cap Country
IMAC Holdings IMAC Holdings
IMAC
- -1.77 % $ 25.4 M usaUSA
ModivCare ModivCare
MODV
- -25.23 % $ 6.12 M usaUSA
DaVita DaVita
DVA
$ 179.27 -3.38 % $ 13.3 B usaUSA
HCA Healthcare HCA Healthcare
HCA
$ 504.51 -0.09 % $ 119 B usaUSA
Chemed Corporation Chemed Corporation
CHE
$ 544.61 1.22 % $ 7.84 B usaUSA
Amedisys Amedisys
AMED
- 0.01 % $ 3.3 B usaUSA
ЮМГ ЮМГ
GEMC
- - - russiaRussia
National HealthCare Corporation National HealthCare Corporation
NHC
$ 209.19 -0.26 % $ 3.24 B usaUSA
Option Care Health Option Care Health
OPCH
$ 31.65 -0.14 % $ 5.13 B usaUSA
Surgery Partners Surgery Partners
SGRY
$ 26.76 1.15 % $ 3.4 B usaUSA
Sanara MedTech Sanara MedTech
SMTI
$ 31.66 -1.37 % $ 273 M usaUSA
Tenet Healthcare Corporation Tenet Healthcare Corporation
THC
$ 290.64 0.57 % $ 26.2 B usaUSA
SunLink Health Systems SunLink Health Systems
SSY
- 17.98 % $ 7.81 M usaUSA
Universal Health Services Universal Health Services
UHS
$ 195.47 -0.86 % $ 12.4 B usaUSA
Мать и Дитя Мать и Дитя
MDMG
- - - russiaRussia
Tivity Health Tivity Health
TVTY
- 0.09 % $ 1.6 B usaUSA
LHC Group LHC Group
LHCG
- - $ 5.27 B usaUSA
AMN Healthcare Services AMN Healthcare Services
AMN
$ 37.77 0.16 % $ 1.45 B usaUSA
Oak Street Health Oak Street Health
OSH
- 0.03 % $ 9.53 B usaUSA
Ontrak Ontrak
OTRK
- -11.98 % $ 1.53 M usaUSA
Novo Integrated Sciences Novo Integrated Sciences
NVOS
- -13.87 % $ 1.52 M usaUSA
American Shared Hospital Services American Shared Hospital Services
AMS
$ 1.2 -2.44 % $ 7.94 M usaUSA
Community Health Systems Community Health Systems
CYH
$ 2.17 -3.76 % $ 290 M usaUSA
Fresenius Medical Care AG & Co. KGaA Fresenius Medical Care AG & Co. KGaA
FMS
$ 22.74 -0.92 % $ 6.62 B germanyGermany
Brookdale Senior Living Brookdale Senior Living
BKD
$ 9.18 -1.4 % $ 2.16 B usaUSA
Acadia Healthcare Company Acadia Healthcare Company
ACHC
$ 38.71 0.25 % $ 3.51 B usaUSA
Addus HomeCare Corporation Addus HomeCare Corporation
ADUS
$ 126.57 3.39 % $ 2.28 B usaUSA
Capital Senior Living Corporation Capital Senior Living Corporation
CSU
- -2.09 % $ 216 M usaUSA
COMPASS Pathways plc COMPASS Pathways plc
CMPS
$ 9.25 0.76 % $ 865 M britainBritain
Elanco Animal Health Incorporated Elanco Animal Health Incorporated
ELAN
$ 27.0 0.6 % $ 13.4 B usaUSA
Concord Medical Services Holdings Limited Concord Medical Services Holdings Limited
CCM
$ 3.68 0.55 % $ 482 M chinaChina
Encompass Health Corporation Encompass Health Corporation
EHC
$ 142.58 1.01 % $ 14.3 B usaUSA
Healthcare Services Group Healthcare Services Group
HCSG
$ 25.29 2.06 % $ 1.83 B usaUSA
New Frontier Health Corporation New Frontier Health Corporation
NFH
- 3.54 % $ 1.5 B usaUSA
The Joint Corp. The Joint Corp.
JYNT
$ 6.84 2.86 % $ 104 M usaUSA
MEDNAX MEDNAX
MD
$ 31.63 0.44 % $ 2.66 B usaUSA
Phibro Animal Health Corporation Phibro Animal Health Corporation
PAHC
$ 34.64 0.09 % $ 1.4 B usaUSA
The Pennant Group The Pennant Group
PNTG
$ 36.8 1.48 % $ 1.27 B usaUSA
Aesthetic Medical International Holdings Group Limited Aesthetic Medical International Holdings Group Limited
AIH
- 10.96 % $ 46.2 M chinaChina
Five Star Senior Living Inc. Five Star Senior Living Inc.
FVE
- -0.32 % $ 98.4 M usaUSA
U.S. Physical Therapy U.S. Physical Therapy
USPH
$ 99.36 -0.48 % $ 1.51 B usaUSA
Genesis Healthcare, Inc. Genesis Healthcare, Inc.
GEN
- - $ 68.1 M usaUSA
Avalon GloboCare Corp. Avalon GloboCare Corp.
AVCO
- 26.45 % $ 70.6 M usaUSA
Apollo Medical Holdings Apollo Medical Holdings
AMEH
- -2.11 % $ 1.84 B usaUSA
The Ensign Group The Ensign Group
ENSG
$ 185.09 1.64 % $ 10.6 B usaUSA
Regional Health Properties Regional Health Properties
RHE
- - $ 5.2 M usaUSA
Select Medical Holdings Corporation Select Medical Holdings Corporation
SEM
- - $ 2.02 B usaUSA